Share chart Celldex Therapeutics, Inc.
Extended chart
Simple chart
About Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc., биофармацевтическая компания, занимается разработкой терапевтических моноклональных и биспецифических антител для лечения различных заболеваний. Его кандидаты в лекарства включают терапевтические препараты на основе антител для лечения пациентов с воспалительными заболеваниями и различными формами рака. more detailsMain settings
| IPO date | 2008-03-10 |
|---|---|
| ISIN | US15117B2025 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | link |
| Цена ао | 20.35 |
| Change price per day: | 0% (20.35) |
|---|---|
| Change price per week: | -2.68% (20.91) |
| Change price per month: | +3.93% (19.58) |
| Change price per 3 month: | -4.59% (21.33) |
| Change price per half year: | -23.95% (26.76) |
| Change price per year: | -44.88% (36.92) |
| Change price per 3 year: | -17.28% (24.6) |
| Change price per 5 year: | +804.44% (2.25) |
| Change price per 10 year: | -32.68% (30.23) |
| Change price per year to date: | -19.02% (25.13) |
Grade
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
Main owners
| Institutions | Volume | Share, % |
|---|---|---|
| FMR, LLC | 10 | 14.76 |
| Wellington Management Group, LLP | 8 | 11.6 |
| Blackrock Inc. | 5 | 6.85 |
| Vanguard Group Inc | 4 | 5.54 |
| Eventide Asset Management LLC | 3 | 4.73 |
| Price (T.Rowe) Associates Inc | 3 | 4.68 |
| Polar Capital Holdings PLC | 3 | 4.64 |
| State Street Corporation | 3 | 4.52 |
| Kynam Capital Management, LP | 3 | 4.4 |
| Bellevue Group AG | 3 | 4.24 |
Contained in ETF
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| iShares Morningstar Small-Cap Growth ETF | 0.1032 | 595.05 | 0.72598 |
| iShares Morningstar Small-Cap ETF | 0.05256 | 391.25 | 1.60498 |
| 0.07 | 493.15 | 1.17 |
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Sam Martin | Senior VP, CFO, Secretary & Treasurer | 617.26k | 1971 (54 years) |
| Ms. Sarah Cavanaugh | Senior Vice President of Corporate Affairs & Administration | N/A | 1975 (50 years) |
| Mr. Freddy A. Jimenez Esq. | Senior VP & General Counsel | 579.7k | 1969 (56 years) |
| Dr. Ronald A. Pepin | Chief Business Officer & Senior VP | 441.84k | 1956 (69 years) |
| Mr. Anthony S. Marucci M.B.A. | Founder, President, CEO & Director | 1.14M | 1962 (63 years) |
| Dr. Diane C. Young M.D. | Senior VP & Chief Medical Officer | 643.5k | 1957 (68 years) |
| Prof. Joseph P. Schlessinger Ph.D. | Co-Founder & Member of Scientific Advisory Board | N/A | 1945 (80 years) |
| Dr. Margo Heath-Chiozzi M.D. | Senior Vice President of Regulatory Affairs | 614.12k | 1957 (68 years) |
| Dr. Tibor Keler Ph.D. | Founder, Chief Scientific Officer & Executive VP | 1959 (66 years) | |
| Ms. Elizabeth Crowley | Chief Product Development Officer & Senior VP | 1972 (53 years) |
About company
Address: United States, Hampton, Perryville III Building - Open in google maps, Open in yandex maps
Website: http://www.celldex.com
Website: http://www.celldex.com
